BIOGEN INC. (BIIB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BIOGEN INC. reported revenue of $9.89B, up 2.2% from the prior year. The company was profitable, with a net margin of 13.1%. It held $29.44B in total assets against $11.18B in total liabilities.
Key ratios (FY2025)
13.1%
Net margin
7.1%
Return on equity
+2.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.89B | $9.68B | $9.84B | $10.17B | $10.98B | $13.44B | $14.38B | $13.45B | $12.27B | $11.45B |
| Cost of Revenue | $2.40B | $2.31B | $2.53B | $2.28B | $2.11B | $1.81B | $1.96B | $1.82B | $1.63B | $1.48B |
| Gross Profit | — | — | — | — | — | $11.64B | $12.42B | $11.64B | $10.64B | $9.97B |
| Operating Income | — | — | — | — | $2.84B | $4.55B | $7.04B | $5.89B | $5.35B | $5.15B |
| Net Income | $1.29B | $1.63B | $1.16B | $3.05B | $1.56B | $4.00B | $5.89B | $4.43B | $2.54B | $3.70B |
| EPS (Diluted) | $8.79 | $11.18 | $7.97 | $20.87 | $10.40 | $24.80 | $31.42 | $21.58 | $11.92 | $16.93 |
| Total Assets | $29.44B | $28.05B | $26.84B | $24.55B | $23.88B | $24.62B | $27.23B | $25.29B | $23.65B | $22.88B |
| Total Liabilities | $11.18B | $11.33B | $12.05B | $11.17B | $12.92B | $13.93B | $13.90B | $12.26B | $11.05B | $10.75B |
| Shareholders' Equity | $18.26B | $16.72B | $14.80B | $13.39B | $10.96B | $10.69B | $13.34B | $13.03B | $12.60B | $12.13B |
| Cash & Equivalents | — | — | — | — | — | — | $2.91B | $1.22B | $1.57B | $2.33B |
| Operating Cash Flow | $2.20B | $2.88B | $1.55B | $1.38B | $3.64B | $4.23B | $7.08B | $6.19B | $4.55B | $4.59B |
| Capital Expenditures | $153.80M | $153.70M | $277.00M | $240.30M | $258.10M | $424.80M | $514.50M | $770.60M | $867.40M | $616.10M |
| Shares Outstanding | 147.10M | 145.90M | 145.60M | 146.00M | 149.60M | 161.30M | 187.40M | 205.30M | 213.00M | 218.80M |